Skip to main content alibris logo

Reprogramming the Genome: Crispr-Cas-Based Human Disease Therapy: Volume 181

by

Write The First Customer Review
Reprogramming the Genome: Crispr-Cas-Based Human Disease Therapy: Volume 181 - Singh, Vijai
Filter Results
Shipping
Item Condition
Seller Rating
Other Options
Change Currency

Reprogramming the Genome: CRISPR-Cas-based Human Disease Therapy , presents the collation of chapters written by eminent scientists worldwide. CRISPR-Cas9 is a key technology for targeted genome editing and regulation in a number of organisms including mammalian cells. It is a rapid, simple, and cost-effective solution. CRISPR-Cas system has recently gained much scientific and public attention. This volume covers CRISPR-Cas9 based mammalian genome editing, creating disease models, cancer therapy, neurological, heredity, ...

loading
Reprogramming the Genome: Crispr-Cas-Based Human Disease Therapy: Volume 181 2021, Academic Press

ISBN-13: 9780323853231

Hardcover